ASTRO

This page includes the latest news from the American Society of Radiation Oncology (ASTRO), including news and video coverage from the society's annual meeting. ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other healthcare professionals who specialize in treating patients with radiation therapy. 

At the annual meeting of ASTRO, the American Society for Therapeutic Radiology and Oncology, MSK Radiation Oncology Department Chair Dr. Simon Powell was honored with ASTRO’s highest honor, the Gold Medal Award.
News | Radiation Therapy
Advances from MSK Researchers Reported at 2023 ASTRO Meeting

October 5, 2023 — Researchers from Memorial Sloan Kettering Cancer Center (MSK) were recognized for their achievements ...

Time October 05, 2023
arrow
Mevion and RaySearch re-imagine novel solutions to advance the use of emerging proton therapy technologies
News | Proton Therapy
Mevion and RaySearch: A Synergy of Innovation Transforming Proton Therapy

October 3, 2023 — Mevion Medical Systems, the leading global provider of compact proton therapy solutions, and RaySearch ...

Time October 03, 2023
arrow
Featuring presentations on novel combination therapies and analytical methods
News | Radiology Business
MD Anderson Research Highlights: ASTRO 2023 Special Edition

October 3, 2023 — The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest ...

Time October 03, 2023
arrow
News | ASTRO
Multi-Institutional Study Data Presented at ASTRO 2023 Builds Upon Growing Evidence of GammaTile for Patients with Brain Tumors

October 3, 2023 — Medical device company GT Medical Technologies, Inc. announced interim findings of a multi ...

Time October 03, 2023
arrow
Study finds CT simulation scans may not always be needed for simple plans
News | Computed Tomography (CT)
Using Recent Diagnostic Scans Can Substantially Cut Time to Treatment for Patients Needing Urgent Palliation

October 3, 2023 — Using previously taken diagnostic computed tomography (CT) scans in place of CT simulation scans to ...

Time October 03, 2023
arrow
Findings suggest levels of circulating tumor DNA are more important than the number of lesions in determining disease burden
News | Lung Imaging
Liquid Biopsy May Help Identify Which Patients with Non-small Cell Lung Cancer Will Benefit Most from Radiation

October 2, 2023 — A novel liquid biopsy test may help determine which patients with non-small cell lung cancer that has ...

Time October 02, 2023
arrow
Shorter treatment course found as effective as longer schedule for people with non-HPV-related locally advanced disease
News | Radiation Therapy
Accelerated Radiation Treatment Could Reduce Head and Neck Cancer Patient Burden in Low- and Middle-income Countries

October 2, 2023 — A type of head and neck cancer predominantly diagnosed in people who reside in low- and middle-income ...

Time October 02, 2023
arrow
Non-invasive tests may help identify patients facing higher risk for cervical cancer recurrence, enabling early intervention
News | Radiation Oncology
Liquid Biopsies Can Rapidly Detect Residual Disease Following Cervical Chemoradiation, Study Finds

October 2, 2023 — Two liquid biopsy tests that look for the presence of human papillomavirus (HPV) in the blood ...

Time October 02, 2023
arrow
Findings suggest clinical navigators could help mitigate health inequities
News | Prostate Cancer
Precision Medicine Navigators Increase Genomic Testing Rates for Black Patients with Prostate Cancer

October 1, 2023 — The presence of a clinical navigator to act as a liaison between people with prostate cancer and the ...

Time October 01, 2023
arrow
Fuse also announces Syntyant, a new interoperable platform for RadOnc providing seamless connectivity among diverse healthcare technologies to accelerate delivery of care
News | Information Technology
Fuse Oncology Unveils FuseDocs: Newest RadOnc Solution for Streamlining Clinical Documentation for Radiation Oncologists

September 29, 2023 — Fuse Oncology (Fuse) a trailblazing leader in radiation oncology software solutions, unveils their ...

Time September 29, 2023
arrow
RayStation 2023B offers support for automatic field-in-field planning for photons, a method which generates homogeneous and conformal dose distributions
News | Oncology Information Management Systems (OIMS)
Latest innovations in RayStation, RayCare and RayIntelligence to be presented at ASTRO 2023

September 29, 2023 — RaySearch will be showcasing the latest software innovations at ASTRO in San Diego, California ...

Time September 29, 2023
arrow
Introducing five new product iterations across the entire portfolio
News | Radiation Therapy
Together with Siemens Healthineers, Varian Demonstrates Commitment to Embracing Innovation and Enhancing Outcomes at ASTRO 2023

September 29, 2023 — Varian, a Siemens Healthineers company, is showcasing technologies that reflect its continued ...

Time September 29, 2023
arrow
News | ASTRO
Abstract Award Winners Announced at ASTRO 2023

October 1, 2023 — The 2023 Abstract Award winners have been announced by the American Society for Radiation Oncology ...

Time October 01, 2023
arrow
First randomized study shows accelerated treatment saves patients time and money and reduces treatment breaks
News | Women's Health
Short-course Radiation as Effective as Standard Treatment for Patients Who Opt for Breast Reconstruction After Mastectomy

October 1, 2023 — In a first-of-its-kind study, people with breast cancer who underwent implant-based breast ...

Time October 01, 2023
arrow
Multi-center study achieves durable local control and cancer-specific survival after stereotactic radiation treatment
News | Stereotactic Body Radiation Therapy (SBRT)
High-dose Radiation Offers New Treatment Option for Older Patients with Inoperable Kidney Tumors

October 1, 2023 — Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted ...

Time October 01, 2023
arrow
Study points to options to improve quality of life for patients whose cancer is cured with chemoradiation
News | Women's Health
Sexual Activity and Vaginal Dilation Associated with Fewer Side Effects After Cervical Cancer Treatment

October 1, 2023 — People who engage in sexual activity or vaginal dilation after chemoradiation treatment for cervical ...

Time October 01, 2023
arrow
Phase III trial finds fewer, higher doses cut treatment time while maintaining high rates of cure
News | Prostate Cancer
SBRT as Effective as Conventional Radiation for People with Intermediate Risk, Localized Prostate Cancer

September 29, 2023 — People with intermediate risk, localized prostate cancer can be treated as effectively using fewer ...

Time September 29, 2023
arrow
Mevion Medical Systems to showcase the MEVION S250-FIT Proton Therapy System, a revolutionary patient-centric proton therapy solution designed to FIT in a conventional LINAC vault
News | Proton Therapy
Re-Imagine Proton Therapy: Mevion Breaks Down Barriers at ASTRO 2023

September 28, 2023 — Mevion Medical Systems, the leading provider of compact single-room proton therapy systems, will ...

Time September 28, 2023
arrow
RefleXion Showcases Breakthrough SCINTIX Biology-Guided Radiotherapy
News | Radiation Therapy
RefleXion Showcases Breakthrough SCINTIX Biology-Guided Radiotherapy and Highlights New Research at ASTRO 2023 Meeting

September 28, 2023 — RefleXion Medical, a therapeutic oncology company, announced the company will showcase the ...

Time September 28, 2023
arrow
POSLUMA is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer with suspected metastasis
News | Radiopharmaceuticals and Tracers
Blue Earth Diagnostics Highlights Presentations on POSLUMA (Flotufolastat F 18) in Prostate Cancer at Upcoming ASTRO Annual Meeting

September 27, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time September 27, 2023
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now